A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.

This study has been withdrawn prior to recruitment.

( Study was cancelled before patient enrollment )

Study NCT00386555 Information provided by Pfizer

First Received: October 6, 2006 Last Updated: June 6, 2007 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Carcinoma
Lung Neoplasms

More general conditions related to this trial

Interventions listed in this trial

More general drug interventions related to this trial

Sponsors listed in this trial

Pfizer